Jerome Graber
A5036417448- Glioma Diagnosis and Treatment
- CNS Lymphoma Diagnosis and Treatment
- Brain Metastases and Treatment
- Autoimmune Neurological Disorders and Treatments
- Lymphoma Diagnosis and Treatment
- MRI in cancer diagnosis
- Multiple Sclerosis Research Studies
- COVID-19 and healthcare impacts
- Palliative Care and End-of-Life Issues
- COVID-19 Clinical Research Studies
- Radiomics and Machine Learning in Medical Imaging
- Advanced MRI Techniques and Applications
- Management of metastatic bone disease
- Advances in Oncology and Radiotherapy
- Meningioma and schwannoma management
- Peripheral Neuropathies and Disorders
- Cancer-related cognitive impairment studies
- Polyomavirus and related diseases
- Cytomegalovirus and herpesvirus research
- Lung Cancer Research Studies
- Neuroblastoma Research and Treatments
- Economic and Financial Impacts of Cancer
- Genetic Neurodegenerative Diseases
- Chromatin Remodeling and Cancer
- Cancer, Hypoxia, and Metabolism
University of Washington
2019-2025
University of Washington Medical Center
2021-2025
Fred Hutch Cancer Center
2024-2025
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa
2024
Allen Institute for Brain Science
2024
Seattle University
2021-2023
Montefiore Medical Center
2012-2022
Albert Einstein College of Medicine
2012-2022
Neurology, Inc
2021-2022
Swedish Medical Center
2018-2021
<h3>Importance</h3> COVID-19 is a life-threatening illness for many patients. Prior studies have established hematologic cancers as risk factor associated with particularly poor outcomes from COVID-19. To our knowledge, no beneficial role anti–COVID-19 interventions in this at-risk population. Convalescent plasma therapy may benefit immunocompromised individuals COVID-19, including those cancers. <h3>Objective</h3> evaluate the association of convalescent treatment 30-day mortality...
Histone 3 (H3) K27M-mutant diffuse midline glioma (DMG) has a dismal prognosis with no established effective therapy beyond radiation. This integrated analysis evaluated single-agent ONC201 (dordaviprone), first-in-class imipridone, in recurrent H3 DMG.
To examine the potential utility of conventional MRI signs in differentiating pseudoprogression (PsP) from early progression (EP).This retrospective study reviewed initial postradiotherapy scans 321 patients with glioblastoma undergoing chemotherapy and radiotherapy. A total 93 were found to have new or increased enhancing mass lesions, raising possibility PsP. Final diagnosis PsP EP was established upon review surgical specimens a second resection by clinical radiologic follow-up. 11...
<h3>Importance</h3> Non-Hispanic Black individuals experience a higher burden of COVID-19 than the general population; hence, there is an urgent need to characterize unique clinical course and outcomes in patients with cancer. <h3>Objective</h3> To investigate racial disparities severity presentation, complications, between non-Hispanic White cancer COVID-19. <h3>Design, Setting, Participants</h3> This retrospective cohort study used data from Cancer Consortium registry March 17, 2020,...
There is a paucity of large-scale data delineating outcomes and prognostication older patients with primary central nervous system lymphoma (PCNSL). We retrospectively analyzed 539 newly-diagnosed PCNSL ages ≥60 years across 20 U.S. academic centers. The median age was 70 (range 60-88); at least one geriatric syndrome present in 46%; the Cumulative Index Ratings Scale-Geriatrics (CIRS-G) score 6 (range, 0-27); 36% had impairment activities daily living (ADL). most common induction regimens...
"HSR25-185: A Multicenter Retrospective Study of Treatment and Survival Outcomes Patients With Secondary CNS Relapsed DLBCL in the Modern Era" published on 28 Mar 2025 by National Comprehensive Cancer Network.
Background: Tumor treatment is the mainstay of therapy for paraneoplastic neurologic disorders (PNDs), but it only effective in some cases and other options are limited.Objective: To evaluate short-term use a combination prednisone tacrolimus acute worsening PND which intracellular antigens targeted.Design: Retrospective single-center case series patients with treated tacrolimus.Setting: The Rockefeller University Hospital, research hospital New York,
Epidermal growth factor receptor amplification is a common molecular event in glioblastomas. The purpose of this study was to examine the potential usefulness morphologic and diffusion MR imaging signs prediction epidermal gene status patients with glioblastoma.We analyzed pretreatment scans from 147 consecutive newly diagnosed glioblastoma correlated features tumor status. following were qualitatively assessed: 1) border sharpness, 2) cystic/necrotic change, 3) hemorrhage, 4) T2-isointense...